Ergomed acquires Haemostatix
Ergomed is acquiring Haemostatix from a group of UK-based VC investors including Albion Ventures, Catapult Ventures, Esperante, as well as Nesta and the Wellcome Trust for an initial consideration of GBP8.0 million, with a contingent consideration of GBP20.0 million. Nottingham based Haemostatix, a spin-out of the University of Nottingham, is


